GP2 has been detected in the blood of patients affected by various pancreatic diseases including both pancreatic cancer and pancreatitis [29], thus we sought to enumerate GPC1-GP2 dual positive EVs in patient plasma samples representing various stages of pancreatic cancer development. This evidence concerns the gene GPC1 and pancreatic neoplasm.